These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34590021)

  • 21. Malignant pleural mesothelioma: a population-based study of survival.
    Milano MT; Zhang H
    J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
    Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
    Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with 
Malignant Pleural Mesothelioma].
    Zeng X; Jiang Z; Duan J
    Zhongguo Fei Ai Za Zhi; 2022 Jan; 25(1):7-13. PubMed ID: 35078279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rosenzweig KE; Zauderer MG; Laser B; Krug LM; Yorke E; Sima CS; Rimner A; Flores R; Rusch V
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1278-83. PubMed ID: 22607910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
    Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
    Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
    Scherpereel A; Mazieres J; Greillier L; Lantuejoul S; Dô P; Bylicki O; Monnet I; Corre R; Audigier-Valette C; Locatelli-Sanchez M; Molinier O; Guisier F; Urban T; Ligeza-Poisson C; Planchard D; Amour E; Morin F; Moro-Sibilot D; Zalcman G;
    Lancet Oncol; 2019 Feb; 20(2):239-253. PubMed ID: 30660609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.
    Chen D; Li X; Zhao H; Fu Y; Yao F; Hu J; Du N
    Indian J Cancer; 2014 Mar; 51 Suppl 3():e82-5. PubMed ID: 25818740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
    Li L; Razak AR; Hughes A
    Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the biology of malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
    Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant pleural mesothelioma with an unusual radiologic manifestation].
    Jover-Sáenz A; Vilà-Justribó M; Salud-Salvià A; Porcel-Pérez JM; Vicente de Vera P
    An Med Interna; 1999 Jul; 16(7):354-6. PubMed ID: 10481335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not everything is what it seems: malignant pleural mesothelioma mimicking lung cancer.
    Prisciandaro E; Girelli L; Rampinelli C; Ghioni M; Spaggiari L
    Adv Respir Med; 2019; 87(6):265-267. PubMed ID: 31970729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.
    Shepherd KE; Oliver LC; Kazemi H
    Am J Ind Med; 1989; 16(4):373-83. PubMed ID: 2610210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.
    Augeri S; Capano S; Morone S; Fissolo G; Giacomino A; Peola S; Drace Z; Rapa I; Novello S; Volante M; Righi L; Ferrero E; Ortolan E; Funaro A
    Oncotarget; 2018 Apr; 9(32):22785-22801. PubMed ID: 29854315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
    Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
    J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
    Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
    Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Computed tomography findings of malignant pleural mesothelioma].
    Shiota Y; Sato T; Yamaguchi K; Ono T; Kaji M; Niiya H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Apr; 32(4):309-14. PubMed ID: 8041037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
    Nowak AK; Lesterhuis WJ; Kok PS; Brown C; Hughes BG; Karikios DJ; John T; Kao SC; Leslie C; Cook AM; Pavlakis N; Briscoe K; O'Byrne KJ; Karapetis CS; Lam WS; Langford A; Yip S; Stockler MR
    Lancet Oncol; 2020 Sep; 21(9):1213-1223. PubMed ID: 32888453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial.
    Disselhorst MJ; Quispel-Janssen J; Lalezari F; Monkhorst K; de Vries JF; van der Noort V; Harms E; Burgers S; Baas P
    Lancet Respir Med; 2019 Mar; 7(3):260-270. PubMed ID: 30660511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.
    Tian L; Zeng R; Wang X; Shen C; Lai Y; Wang M; Che G
    Oncotarget; 2017 Jul; 8(28):46425-46435. PubMed ID: 28507279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.